Stephen A Sherwin Neurocrine Biosciences Inc (NBIX) insider trading activity

Stephen A Sherwin is Director of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 10,673 shares of NBIX, which is worth approximately $1.27 Million. The most recent transaction as insider was on Feb 13, 2025, when has been sold 13,831 shares (Common Stock) at a price of $116.69 per share, resulting in proceeds of $1,613,939. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.7K

56.44% 3M change

52.15% 12M change

Total Value Held $1.27 Million

STEPHEN A SHERWIN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 13 2025	SELL Open market or private sale	$1,613,939 $116.69 p/Share	13,831 Reduced 56.44%	10,673 Common Stock
Nov 04 2024	SELL Bona fide gift	-	2,000 Reduced 7.55%	24,504 Common Stock
May 29 2024	SELL Open market or private sale	$5,338,800 $133.47 p/Share	40,000 Reduced 60.15%	26,504 Common Stock
May 29 2024	BUY Exercise of conversion of derivative security	$1,812,800 $45.32 p/Share	40,000 Added 49.08%	41,504 Common Stock
May 17 2024	BUY Exercise of conversion of derivative security	-	4,199 Added 13.68%	26,504 Common Stock
Nov 16 2023	SELL Bona fide gift	-	2,750 Reduced 10.98%	22,305 Common Stock
Jan 03 2023	SELL Open market or private sale	$3,565,800 $118.86 p/Share	30,000 Reduced 54.49%	25,055 Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	$385,500 $12.85 p/Share	30,000 Added 42.82%	40,055 Common Stock
Jan 24 2022	SELL Open market or private sale	$1,116,450 $74.43 p/Share	15,000 Reduced 37.45%	25,055 Common Stock
Jan 24 2022	BUY Exercise of conversion of derivative security	$99,900 $6.66 p/Share	15,000 Added 27.25%	40,055 Common Stock
Dec 14 2021	SELL Bona fide gift	-	2,000 Reduced 7.39%	25,055 Common Stock
Dec 03 2020	SELL Bona fide gift	-	2,806 Reduced 9.4%	27,055 Common Stock

Also insider at

BIIB

BIOGEN INC. Healthcare

Director

SAS